BioRestorative Therapies, Inc. (OTCMKTS:BRTXQ – Get Free Report)’s stock price reached a new 52-week high during trading on Monday . The company traded as high as $1.48 and last traded at $1.46, with a volume of 43606 shares trading hands. The stock had previously closed at $1.45.
BioRestorative Therapies Stock Performance
The firm has a market cap of $2.54 billion, a price-to-earnings ratio of -1.45 and a beta of 102.36. The company has a 50 day moving average price of $1.55 and a 200 day moving average price of $1.62.
BioRestorative Therapies Company Profile
BioRestorative Therapies, Inc develops therapeutic products using cell and tissue protocols primarily involving adult stem cells. The company’s two core programs are related to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program includes a lead cell therapy candidate, BRTX-100 is a product formulated from autologous (or a person's own) cultured mesenchymal stem cells collected from the patient's bone marrow and intended for the non-surgical treatment of painful lumbosacral disc disorders.
Recommended Stories
- Five stocks we like better than BioRestorative Therapies
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- Novo Nordisk: A New Boost for GLP-1 Sales on the Horizon
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- Why Now Is the Ultimate Time to Invest in Oil Stocks
- How to Most Effectively Use the MarketBeat Earnings Screener
- Q4’s Most Upgraded Stocks: Promising Buys for 2025
Receive News & Ratings for BioRestorative Therapies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioRestorative Therapies and related companies with MarketBeat.com's FREE daily email newsletter.
